Related Experiment Video
Updated: May 26, 2026
08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
Hematopoietic cell transplantation for nonmalignant disorders
Jakub Tolar1, Parinda A Mehta, Mark C Walters
1Blood and Marrow Transplantation, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Summary
Hematopoietic cell transplantation (HCT) offers cures for hereditary stem cell disorders and shows promise for nonhematopoietic conditions. Advances in donor selection and conditioning have improved HCT outcomes for various genetic diseases.
Area of Science:
- * Hematology and Transplant Medicine
- * Genetic and Hereditary Disorders
Background:
- * Hematopoietic stem cell (HSC) disorders have historically been treated with allogeneic therapy.
- * Hematopoietic cell transplantation (HCT) was one of the first curative therapies for human diseases.
- * Emerging research explores HCT for nonhematopoietic hereditary disorders by ameliorating target organ damage.
Purpose of the Study:
- * To provide an update on the application of HCT for hereditary marrow failure syndromes and hemoglobin disorders.
- * To present a novel indication for HCT in epidermolysis bullosa.
- * To illustrate the expanding potential of HCT for nonmalignant disorders.
Main Methods:
- * Review of advancements in donor selection and patient risk stratification.
- * Modifications to conditioning regimens for HCT.
- * Case examples of HCT application in specific hereditary disorders.
Main Results:
- * Significant improvements in HCT outcomes over the past three decades.
- * Encouraging results in treating nonhematopoietic hereditary disorders.
- * Successful application of HCT for hereditary marrow failure, hemoglobin disorders, and epidermolysis bullosa.
Conclusions:
- * HCT is a well-established curative therapy for HSC-derived hereditary disorders.
- * HCT demonstrates expanding potential for treating a broader range of nonmalignant hereditary conditions.
- * Refined HCT protocols enhance safety and efficacy for nonmalignant indications.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:01Regulation of Hematopoietic Stem Cells
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
01:21Hematopoiesis
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...